1. 821Daclatasvir and Asunaprevir Plus Peginterferon Alfa-2a and Ribavirin in Patients With HCV Genotype 1 or 4 Infection: Phase 3 HALLMARK-QUAD Results. (December 2014) Authors: Jensen, Donald M.; Sherman, Kenneth; Hezode, Christophe; Pol, Stanislas; Zeuzem, Stefan; De Ledinghen, Victor; Tran, Albert; Elkhashab, Magdy; Younes, Ziad H; Kugelmas, Marcelo; Mauss, Stefan; Everson, Gregory T.; Luketic, Velimir; Vierling, John; Serfaty, Lawrence; Brunetto, Maurizia; Heo, Jeong... Journal: Open forum infectious diseases Issue: Volume 1(2014)Supplement 1 Page Start: S234 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A pooled analysis of patients with wound infections in the Phase 3 REVIVE trials: randomized, double-blind studies to evaluate the safety and efficacy of iclaprim versus vancomycin for treatment of acute bacterial skin and skin structure infections. Issue 4 (20th March 2020) Authors: Noviello, Stephanie; Corey, G. Ralph; Holland, Thomas L.; Lodise, Thomas; O'Riordan, William; Wilcox, Mark H.; File, Thomas M.; Dryden, Matthew; Balser, Barbara; Scaramucci, Amy; Torres, Antoni; Huang, David B. Journal: Journal of medical microbiology Issue: Volume 69:Issue 4(2020) Page Start: 625 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. All‐oral daclatasvir plus asunaprevir for chronic hepatitis C virus (HCV) genotype 1b infection: a sub‐analysis in Asian patients from the HALLMARK DUAL study. (28th April 2016) Authors: Kao, Jia‐Horng; Lee, Youn‐Jae; Heo, Jeong; Ahn, Sang‐Hoon; Lim, Young‐Suk; Peng, Cheng‐Yuan; Chang, Ting‐Tsung; Torbeyns, Anne; Hughes, Eric; Bhore, Rafia; Noviello, Stephanie Journal: Liver international Issue: Volume 36:Number 10(2016) Page Start: 1433 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Case report: successful retreatment of hepatitis C genotype 1b infection with sofosbuvir + simeprevir in a patient with cirrhosis who had prior virologic relapse after treatment with daclatasvir and asunaprevir. Issue 7 (1st June 2016) Authors: Safadi, Rifaat; Noviello, Stephanie; Boparai, Navdeep; McPhee, Fiona Journal: Clinical case reports Issue: Volume 4:Issue 7(2016) Page Start: 653 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Daclatasvir + sofosbuvir versus standard of care for hepatitis C genotype 3: a matching-adjusted indirect comparison. (March 2016) Authors: Swallow, Elyse; Song, Jinlin; Yuan, Yong; Kalsekar, Anupama; Kelley, Caroline; Mu, Fan; Kim, Soomi; Noviello, Stephanie; Signorovitch, James Journal: Journal of comparative effectiveness research Issue: Volume 5:Number 2(2016) Page Start: 129 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Daclatasvir + sofosbuvir versus standard of care for hepatitis C genotype 3: a matching-adjusted indirect comparison. (March 2016) Authors: Swallow, Elyse; Song, Jinlin; Yuan, Yong; Kalsekar, Anupama; Kelley, Caroline; Mu, Fan; Kim, Soomi; Noviello, Stephanie; Signorovitch, James Journal: Journal of comparative effectiveness research Issue: Volume 5:Number 2(2016) Page Start: 129 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Daclatasvir + sofosbuvir versus standard of care for hepatitis C genotype 3: a matching-adjusted indirect comparison. (March 2016) Authors: Swallow, Elyse; Song, Jinlin; Yuan, Yong; Kalsekar, Anupama; Kelley, Caroline; Mu, Fan; Kim, Soomi; Noviello, Stephanie; Signorovitch, James Journal: Journal of comparative effectiveness research Issue: Volume 5:Number 2(2016) Page Start: 129 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Daclatasvir and Sofosbuvir with Ribavirin for 24 Weeks in Chronic Hepatitis C Genotype-3-Infected Patients with Cirrhosis: A Phase III Study (ALLY-3C). Issue 1 (January 2019) Authors: Poordad, Fred; Shiffman, Mitchell L; Ghesquiere, Wayne; Wong, Alexander; Huhn, Gregory D; Wong, Florence; Ramji, Alnoor; Shafran, Stephen D; McPhee, Fiona; Yang, Rong; Noviello, Stephanie; Linaberry, Misti Journal: Antiviral therapy Issue: Volume 24:Issue 1(2019) Page Start: 35 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Daclatasvir plus asunaprevir for HCV genotype 1b infection in patients with or without compensated cirrhosis: a pooled analysis. (24th January 2016) Authors: Kao, Jia‐Horng; Jensen, Donald M.; Manns, Michael P.; Jacobson, Ira; Kumada, Hiromitsu; Toyota, Joji; Heo, Jeong; Yoffe, Boris; Sievert, William; Bessone, Fernando; Peng, Cheng‐Yuan; Roberts, Stuart K.; Lee, Youn‐Jae; Bhore, Rafia; Mendez, Patricia; Hughes, Eric; Noviello, Stephanie Journal: Liver international Issue: Volume 36:Number 7(2016) Page Start: 954 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Daclatasvir plus peginterferon alfa and ribavirin for treatment-naive chronic hepatitis C genotype 1 or 4 infection: a randomised study. Issue 6 (30th July 2014) Authors: Hézode, Christophe; Hirschfield, Gideon M; Ghesquiere, Wayne; Sievert, William; Rodriguez-Torres, Maribel; Shafran, Stephen D; Thuluvath, Paul J; Tatum, Harvey A; Waked, Imam; Esmat, Gamal; Lawitz, Eric J; Rustgi, Vinod K; Pol, Stanislas; Weis, Nina; Pockros, Paul J; Bourlière, Marc; Serfaty, Law... Journal: Gut Issue: Volume 64:Issue 6(2015) Page Start: 948 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗